CYCLOTRON PRODUCED RADIOPHARMACEUTICALS

Karel Kopicka

Nuclear Physics Institute, Czech Academy of Sciences, Rez

WHAT IS A RADIOPHARMACEUTICAL?

Radioactive product fulfilling all pharmaceutical requirements and intended for in vivo administration in humans with special purpose to carry out diagnostic or therapeutic procedure

REQUIREMENTS TO BE MET BY RADIOPHARMACEUTICALS

TYPICAL STRUCTURE OF A RADIOPHARMACEUTICAL

CARRIER + RADIONUCLIDE

Carrier: provides for the affinity to a special body tissue

Radionuclide: intended to the purpose of detection only (diagnostics) or interaction with the tissue (therapeutics)

Example of a diagnostic radiopharmaceutical

123I - hippurate: thanks to its elimination from the body via renal tubular excretion, it is accumulated in kidneys, therefore the function of kidneys may be monitored and the kidneys may be visualised

Example of a therapeutic radiopharmaceutical

131I - sodium iodide: copies the natural metabolism of I" ions and accumulates in the thyroid gland; thanks to heavy accumulation in the target tissue and high LET of the beta particles in the tissue, the hyperplasia or cancer cells of the thyroid gland may be destroyed

SOURCES OF RADIONUCLIDES

• Naturally occurring radionuclides

• Radionuclides produced by reactor:

- by irradiation

- products of uranium fission

• Radionuclides produced by cyclotron

• Generator radionuclides

SPECIAL CONDITIONS FOR PRODUCTION OF RADIOACTIVE DRUGS

• Special areas under closure, fulfilling the demands for work with radionuclides and drug production

• Special equipment

• Special procedures

• Specially trained team

SPECIAL AREAS FOR RADIOPHARMACEUTICAL PRODUCTION

SPECIAL EQUIPMENT

SPECIAL PROCEDURES VARIABILITY OF RADIOPHARMACEUTICALS (EXAMPLE OF IODINE ISOTOPES)
 
Radionuclide and its source Type of decay Half life Energy (MeV) Use
131 I (reactor, fission products) b- 8.05 d b-0.61 (87%), g 0.364 (82%) Diagnostics, therapeutics (in vivo)
125 I (reactor) K 57.4 d 0.035 (100%) In vitro
123 I (cyclotron) K 13 h 0.159 (100%) Replacement of 131 I
124 I (cyclotron) b+ (28%) K (72%) 4.2 d 0.511

PET?

EXAMPLES OF IODINE RADIOPHARMACEUTICALS
 
131 I - Iortho-iodo-hippurate Diagnostics — isotope nephrography, renal scintigraphy
131 I - meta-iodo-benzylguanidine Therapy - feochromocytoma, neuroblastoma
125 I - ortho-iodo-hippurate Diagnostics - isotope nephrography of children
125 I - labelled compounds for RIA In vitro diagnostics
123 I - meta-iodo-benzylguanidine Diagnostics - feochromocytoma, neuroblastoma
124 I - ? Theoretical possibility of PET-examination of various tissues (so far not used with this radionuclide)

THE IMPORTANCE OF TECHNEGIUM 99mTc IN NUCLEAR MEDICINE

CYCLOTRON PRODUCED RADIOPHARMACEUTICALS
 
Radio-nuclide Radio-pharmaceutical Half-life g -energy (MeV) Use
67Ga 67Ga-citrate 77.9 h 0.092 (62%) Diagnostics of inflammation sites / tumors
81m Kr Generator

81Rb/81mKr

Rb 4.7 h 

Kr 13 s

0.190 (100%) Lung ventilation
111In 111InCl 2,81 d 0,247, 0.173 Labelling of blood elements, sometimes substitution of 99mTc
123I 123I - ortho-iodo-hippurate 13 h 0.159 (100%) Diagnostics of kidney
123I 123I - meta-iodo-benzylguanidine  

 

Diagnostics of feochromocytoma, neuroblastoma
201Tl 201Tl chloride 72 h 0.167, 0.135 Heart diagnostics
18F 18F - -fluor-deoxy-glucose 1.87h 0.511 Diagnostics of brain, heart

 

QUALITY ASSURANCE AND QUALITY CONTROL OF RADIOPHARMACEUTICALS

Quality assurance: Good Manufacturing Practice + Quality Control

Identity check :- half-life measurement

- type and energy of radiation (gamma-spectrometry)

-various checks of the carrier

Content: - radioactivity determination - determination of specific radioactivity (per unit) -determination of the carrier content Purity: - radionuclidic purity (gamma spectrometry) - radiochemical purity

- chemical purity

- special checks (sterility, apyrogenity)

LOGISTICS An example: production of 81Rb/ 81mKr generators

EXAMPLE OF MANUFACTURING SCHEDULE - 81Rb/81mKr generators
 
Monday & Thursday morning Preparation of the target & documentation

Order deadline

5,30 -7,30 p.m. Irradiation
7,45 - 8,30 p.m. Target processing, production of 81Rb
8,30-10,30 p.m. Production of generators
10,30 p.m. - 0,30 a.m. Quality control
0,30-2,30 a.m. Packaging of generators
4,45 a.m. Transport to the customers
Tuesday, Friday 8,00 a.m. Use of the generators in hospitals

ASPECTS OF PRODUCTION OF CYCLOTRON RADIOPHARMACEUTICALS

• Target technique

• Technology of radionuclide production

• Carrier labelling

• Special conditions of the production

• Aspects of quality control

• Logistics

Return to Lectures and Seminars